Login

Thalidomide-O-amido-PEG2-C2-NH2 (TFA)

CAT:
804-HY-112617A-04
Size:
500 mg
Price:
Ask
For price, please contact [email protected]
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Thalidomide-O-amido-PEG2-C2-NH2 (TFA) - image 1

Thalidomide-O-amido-PEG2-C2-NH2 (TFA)

  • CAS Number: 1957235-75-4
  • UNSPSC Description: Thalidomide-O-amido-PEG2-C2-NH2 TFA is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and 2-unit PEG linker used in PROTAC technology.
  • Target Antigen: Apoptosis; Autophagy; E3 Ligase Ligand-Linker Conjugates
  • Type: Reference compound
  • Related Pathways: Apoptosis;Autophagy;PROTAC
  • Applications: Cancer-programmed cell death
  • Field of Research: Cancer; Inflammation/Immunology
  • Assay Protocol: https://www.medchemexpress.com/E3_Ligase_Ligand-Linker_Conjugates_24_TFA.html
  • Purity: 99.72
  • Solubility: DMSO : 100 mg/mL (ultrasonic)|H2O : 150 mg/mL (ultrasonic)
  • Smiles: O=C(NCCOCCOCCN)COC1=CC=CC(C(N2C(CC3)C(NC3=O)=O)=O)=C1C2=O.O=C(O)C(F)(F)F
  • Molecular Weight: 576.48
  • References & Citations: [1]ARYL SULFONOHYDRAZIDES. WO 2017/176958 A1.
  • Shipping Conditions: Room Temperature
  • Storage Conditions: 4°C (Powder, sealed storage, away from moisture)
  • Clinical Information: No Development Reported